A practical and rapid screening method for influenza virus neuraminidase inhibitors based on fluorescence detection
- PMID: 36617368
- PMCID: PMC9826620
- DOI: 10.1007/s44211-023-00267-y
A practical and rapid screening method for influenza virus neuraminidase inhibitors based on fluorescence detection
Abstract
A new analytical method for rapid screening of influenza virus neuraminidase inhibitors was established. The method is based on the principle that, given a certain amount of neuraminidase, the sample and the neuraminidase act in the microplate for a period of time, and the active neuraminidase that is not inhibited by the sample can generate a fluorescence value at a specific wavelength after binding to the substrate, and the rate of inhibition of neuraminidase by the sample can be calculated based on the actual detected fluorescence value. This newly developed method was used to screen and evaluate the in vitro anti-neuraminidase activity of 39 high-purity compounds contained in three traditional Chinese herbal medicines, and finally 25 compounds with strong activity were obtained. The newly established neuraminidase inhibitor analytical method has these advantages of practicality, rapidity, high sensitivity and low cost, and has a good value for promotion and application. This article newly establishes a rapid, sensitive, simple and practical screening method for influenza virus neuraminidase inhibitors, which is a great complement to the existing methods and has a good promotion and application value.
Keywords: Fluorescence detection; Influenza virus neuraminidase inhibitor; Molecular docking; Quality consistency; Traditional Chinese medicine.
© 2023. The Author(s), under exclusive licence to The Japan Society for Analytical Chemistry.
Conflict of interest statement
The authors have declared no conflict of interests.
Figures




Similar articles
-
Screening and evaluation of commonly-used anti-influenza Chinese herbal medicines based on anti-neuraminidase activity.Chin J Nat Med. 2016 Oct;14(10):794-800. doi: 10.1016/S1875-5364(16)30095-4. Epub 2016 Oct 31. Chin J Nat Med. 2016. PMID: 28236410
-
Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.Org Biomol Chem. 2011 Aug 21;9(16):5625-9. doi: 10.1039/c1ob05384a. Epub 2011 Jun 30. Org Biomol Chem. 2011. PMID: 21720632
-
Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.Curr Med Chem. 2012;19(34):5885-94. doi: 10.2174/092986712804143358. Curr Med Chem. 2012. PMID: 22963668 Review.
-
Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.J Ethnopharmacol. 2011 Sep 1;137(1):534-42. doi: 10.1016/j.jep.2011.06.002. Epub 2011 Jun 12. J Ethnopharmacol. 2011. PMID: 21699971
-
Synthesis of influenza neuraminidase inhibitors.Curr Opin Drug Discov Devel. 2001 Nov;4(6):776-91. Curr Opin Drug Discov Devel. 2001. PMID: 11899618 Review.
Cited by
-
Fluorescence paper sensor meets magnetic affinity chromatography: discovering potent neuraminidase inhibitors in herbal medicines.Anal Bioanal Chem. 2025 Apr;417(9):1819-1832. doi: 10.1007/s00216-025-05761-y. Epub 2025 Jan 31. Anal Bioanal Chem. 2025. PMID: 39890624
-
Evaluation of therapeutic potentials of selected phytochemicals against Nipah virus, a multi-dimensional in silico study.3 Biotech. 2023 Jun;13(6):174. doi: 10.1007/s13205-023-03595-y. Epub 2023 May 10. 3 Biotech. 2023. PMID: 37180429 Free PMC article.
References
-
- Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB, Engl N. J. Med. 2018;378:345. - PubMed
-
- Chaccour C, Casellas A, Matteo ABD, Pineda I, Fernandez-Montero A, Ruiz-Castillo P, Richardson MA, Rodríguez-Mateos M, Jordán-Iborra C, Brew J, Carmona-Torre F, Giráldez M, Laso E, Gabaldón-Figueira JC, Dobaño C, Moncunill G, Yuste JR, Pozo JLD, Rabinovich NR, Schöning V, Hammann F, Reina G, Sadaba B, Fernández-Alonso M. eClinicalMedicine. 2021;32:100720. doi: 10.1016/j.eclinm.2020.100720. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical